CRAF
AMENDMENT CORRESPONDENCE ENTERED
02/28/2023
Back to search
Official data from USPTO
HYMON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
02/28/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
01/01/2021
Registration date
04/26/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2022
Last transaction
02/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
10/01/2019
First use in commerce
07/15/2020
Drawing code
4
Owner type
99
Owner location
Suzhou, CN
Examiner
SHANOSKI,JOANNA MARIE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HymonBio Co. LTD
Representatives
HymonBio Co. LTD
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposesfor viral detection; Chemical reagents for medical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Disinfectants for medical instruments; Enzyme preparations for medical purposes; Enzymes for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparationsantivirals
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2022
PUBO
PUBLISHED FOR OPPOSITION
02/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2021
ALIE
ASSIGNED TO LIE
12/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/23/2021
GNRT
NON-FINAL ACTION E-MAILED
07/23/2021
CNRT
NON-FINAL ACTION WRITTEN
07/23/2021
DOCK
ASSIGNED TO EXAMINER
07/19/2021
DOCK
ASSIGNED TO EXAMINER
07/14/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/09/2021
NWAP
NEW APPLICATION ENTERED
01/05/2021
Continuous trademark protection
Get notified about every new filing that threatens HYMON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.